No more candidate donations from Glaxo

GlaxoSmithKline announced that it won't spend corporate money on political contributions anymore, saying that it wants to avoid the implication "that corporate political contributions provide us with any special privileges." The company donated more than $585,000 to U.S. candidates this election year. Release | Report

Suggested Articles

Amgen could soon face new competition in the PCSK9 class, but an efficacy boost in treating high-risk heart attack patients could help keep it ahead.

In its quest to become the dominant SGLT2 diabetes med for heart failure, Jardiance is touting DPP-4 inhibitor-topping data to support its case.

Despite having lost some of its novelty, AZ's Brilinta is touting bleeding data over aspirin that could be a big break in acute coronary syndrome.